Alopecia
Conditions
Interventions
Double-arm, double-blind, randomized controlled clinical trial lasting 24 weeks. Experimental group: 28 men with baldness will receive mesotherapy with dutasteride at a dose of 0.01 percent, one ml pe
Sponsors
Departamento de Dermatologia e Radioterapia da Faculdade de Medicina de Botucatu
Faculdade de Medicina de Botucatu
Eligibility
Sex/Gender
Male
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: Males; 25 and 50 years old; diagnosed with Androgenetic Alopecia classified on the Norwood Hamilton scale as 3V, 4 or 5; only those who sign the informed consent form will take part in the study
Exclusion criteria
Exclusion criteria: Patients who present any other causes of hair thinning other than Androgenetic Alopecia; known sensitivity to Dutasteride; diagnosis of previous Erectile Dysfunction; use of therapy to increase hair density in the last four months or previous Hair Transplant at any time; patients with insulin-dependent Diabetes Mellitus; history of Stroke; Cancer; thromboembolic phenomena; use of anticoagulant medications; Psoriasis; Lichen planus; use of exogenous Testosterone or other androgenic anabolic steroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Density variation of terminal hair in the target area | — |
Secondary
| Measure | Time frame |
|---|---|
| Density variation of hair the target area;Standardized Clinical Photography Assessment | — |
Countries
Brazil
Contacts
Public ContactVitoria Pigari
Universidade Estadual Paulista Júlio de Mesquita Filho
Outcome results
None listed